The stock of Aetna Incorporated New (NYSE:AET) registered an increase of 2.12% in short interest. AET’s total short interest was 6.32M shares in September as published by FINRA. Its up 2.12% from 6.19 million shares, reported previously. With 1.46M shares average volume, it will take short sellers 4 days to cover their AET’s short positions. The short interest to Aetna Incorporated New’s float is 1.85%. About 890,020 shares traded hands. Aetna Inc (NYSE:AET) has risen 23.23% since February 8, 2016 and is uptrending. It has outperformed by 6.74% the S&P500.
Aetna Inc. is a diversified healthcare benefits company. The company has a market cap of $40.31 billion. The Firm operates through three divisions: Health Care, Group Insurance and Large Case Pensions. It has a 16.76 P/E ratio. The Health Care segment’s services and products consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative services contact, basis and emerging businesses services and products, such as accountable care solutions .
The institutional sentiment increased to 0.83 in Q2 2016. Its up 0.01, from 0.82 in 2016Q1. The ratio improved, as 50 funds sold all Aetna Inc shares owned while 294 reduced positions. 47 funds bought stakes while 238 increased positions. They now own 313.20 million shares or 5.61% less from 331.82 million shares in 2016Q1.
Michael & Susan Dell Foundation holds 17.84% of its portfolio in Aetna Inc for 140,786 shares. Healthcor Management L.P. owns 1.00 million shares or 6.66% of their US portfolio. Moreover, Hoplite Capital Management L.P. has 5.58% invested in the company for 923,205 shares. The New York-based New Mountain Vantage Advisers L.L.C. has invested 4.9% in the stock. Lyrical Asset Management Lp, a New York-based fund reported 1.90 million shares.
Out of 9 analysts covering Aetna (NYSE:AET), 4 rate it a “Buy”, 0 “Sell”, while 5 “Hold”. This means 44% are positive. $144 is the highest target while $118 is the lowest. The $130.50 average target is 14.23% above today’s ($114.24) stock price. Aetna has been the topic of 11 analyst reports since September 16, 2015 according to StockzIntelligence Inc. Wolfe Research downgraded the stock on July 21 to “Peer Perform” rating.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.